AU2001269833A1 - Use of coiled-coil structural scaffold to generate structure-specific peptides - Google Patents

Use of coiled-coil structural scaffold to generate structure-specific peptides

Info

Publication number
AU2001269833A1
AU2001269833A1 AU2001269833A AU6983301A AU2001269833A1 AU 2001269833 A1 AU2001269833 A1 AU 2001269833A1 AU 2001269833 A AU2001269833 A AU 2001269833A AU 6983301 A AU6983301 A AU 6983301A AU 2001269833 A1 AU2001269833 A1 AU 2001269833A1
Authority
AU
Australia
Prior art keywords
coiled
specific peptides
structural scaffold
generate structure
coil structural
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001269833A
Inventor
Robert S. Hodges
Michael E Houston
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cytovax Biotechnologies Inc
Original Assignee
Cytovax Biotechnologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytovax Biotechnologies Inc filed Critical Cytovax Biotechnologies Inc
Publication of AU2001269833A1 publication Critical patent/AU2001269833A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU2001269833A 2000-06-14 2001-06-14 Use of coiled-coil structural scaffold to generate structure-specific peptides Abandoned AU2001269833A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US21189200P 2000-06-14 2000-06-14
US60211892 2000-06-14
US21338700P 2000-06-23 2000-06-23
US60213387 2000-06-23
PCT/US2001/019168 WO2001096368A2 (en) 2000-06-14 2001-06-14 Use of coiled-coil structural scaffold to generate structure-specific peptides

Publications (1)

Publication Number Publication Date
AU2001269833A1 true AU2001269833A1 (en) 2001-12-24

Family

ID=26906562

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001269833A Abandoned AU2001269833A1 (en) 2000-06-14 2001-06-14 Use of coiled-coil structural scaffold to generate structure-specific peptides

Country Status (6)

Country Link
US (1) US20030021795A1 (en)
EP (1) EP1290019A2 (en)
JP (1) JP2004503565A (en)
AU (1) AU2001269833A1 (en)
CA (1) CA2410604A1 (en)
WO (1) WO2001096368A2 (en)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10201777A1 (en) * 2002-01-17 2003-08-14 Aventis Behring Gmbh Method for the detection of pathogenic prion proteins by mass spectroscopy
US20080027006A1 (en) * 2004-02-12 2008-01-31 The Regents Of The University Of Colorado Compositions And Methods For Modification And Prevention Of Sars Coronavirus Infectivity
WO2005113602A1 (en) * 2004-05-21 2005-12-01 Cytovax Biotechnologies Inc. Coiled-coil microbial antigens
CA2633435A1 (en) * 2004-12-15 2006-06-22 Robert S. Hodges Antimicrobial peptides and methods of use
EP1754717A1 (en) * 2005-08-19 2007-02-21 Université de Lausanne Antigenic peptides and their use
CA2628241C (en) 2005-11-07 2016-02-02 Indiana University Research And Technology Corporation Glucagon analogs exhibiting physiological solubility and stability
AU2008205229B2 (en) * 2007-01-05 2014-03-27 Indiana University Research And Technology Corporation Glucagon analogs exhibiting enhanced solubility in physiological pH buffers
KR20150116465A (en) 2007-02-15 2015-10-15 인디애나 유니버시티 리서치 앤드 테크놀로지 코퍼레이션 Glucagon/glp-1 receptor co-agonists
ES2397488T3 (en) * 2007-07-23 2013-03-07 Sanofi Pasteur Limited Immunogenic polypeptides and monoclonal antibodies
ATE538129T1 (en) * 2007-09-07 2012-01-15 Complix N V NON-NATURAL PROTEINOUS STRUCTURE COMPRISING THREE NON-COVALENTLY ASSOCIATE PEPTIDES
CA2707861A1 (en) 2007-10-30 2009-05-07 Indiana University Research And Technology Corporation Glucagon antagonists
CA2702289A1 (en) * 2007-10-30 2009-05-07 Indiana University Research And Technology Corporation Compounds exhibiting glucagon antagonist and glp-1 agonist activity
KR101455992B1 (en) * 2007-11-14 2014-11-03 엘지전자 주식회사 Method for transmitting singnal in multiple antenna system
WO2009099763A1 (en) * 2008-01-30 2009-08-13 Indiana University Research And Technology Corporation Ester-based peptide prodrugs
GB0801940D0 (en) * 2008-02-01 2008-03-12 Univ Leuven Kath Inhibitors of lentiviral replication
EP2283136A2 (en) * 2008-04-30 2011-02-16 Danisco US Inc. New chimeric alpha-amylase variants
JP5753779B2 (en) * 2008-06-17 2015-07-22 インディアナ ユニバーシティー リサーチ アンド テクノロジー コーポレーションＩｎｄｉａｎａ Ｕｎｉｖｅｒｓｉｔｙ Ｒｅｓｅａｒｃｈ Ａｎｄ Ｔｅｃｈｎｏｌｏｇｙ Ｃｏｒｐｏｒａｔｉｏｎ Glucagon analogs with improved solubility and stability in buffers at physiological pH
NZ589847A (en) 2008-06-17 2013-01-25 Univ Indiana Res & Tech Corp Glucagon/glp-1 receptor co-agonists
EP2952202B1 (en) * 2008-06-17 2017-10-18 Indiana University Research and Technology Corporation Gip-based mixed agonists for treatment of metabolic disorders and obesity
US20100099614A1 (en) * 2008-10-06 2010-04-22 Hodges Robert S Antimicrobial Peptides and Methods of Use
AR074811A1 (en) 2008-12-19 2011-02-16 Univ Indiana Res & Tech Corp PEPTIDE PROFARMACY OF THE GLUCAGON SUPERFAMILY BASED IN AMIDA
US9352015B2 (en) * 2009-06-05 2016-05-31 The Regents Of The University Of Colorado, A Body Corporate Antimicrobial peptides
KR20120087875A (en) 2009-06-16 2012-08-07 인디애나 유니버시티 리서치 앤드 테크놀로지 코퍼레이션 Gip receptor-active glucagon compounds
GB2471692A (en) * 2009-07-08 2011-01-12 Complix Nv HIV gp41-binding single-chain coiled-coil peptide comprising heptad repeats
EP2512503A4 (en) 2009-12-18 2013-08-21 Univ Indiana Res & Tech Corp Glucagon/glp-1 receptor co-agonists
EP2528622A2 (en) * 2010-01-26 2012-12-05 The Regents of the University of Colorado Influenza virus epitopes templated into double-stranded coiled coils and use thereof in immunization
MX2012008603A (en) 2010-01-27 2013-01-25 Univ Indiana Res & Tech Corp Glucagon antagonist - gip agonist conjugates and compositions for the treatment of metabolic disorders and obesity.
CA2797089A1 (en) 2010-05-13 2011-11-17 Indiana University Research And Technology Corporation Glucagon superfamily peptides exhibiting g protein-coupled receptor activity
CA2797095A1 (en) 2010-05-13 2011-11-17 Indiana University Research And Technology Corporation Glucagon superfamily peptides exhibiting nuclear hormone receptor activity
WO2011163012A2 (en) 2010-06-24 2011-12-29 Indiana University Research And Technology Corporation Amide based glucagon superfamily peptide prodrugs
BR112013013702A2 (en) 2010-12-03 2016-09-13 Sanofi Pasteur Ltd composition for immunization against streptococcus pneumoniae
BR112013015389A2 (en) 2010-12-22 2016-11-22 Univ Indiana Res & Tech Corp glucagon analog displaying gip receptor activity
CN103857408B (en) 2011-06-22 2017-04-12 印第安那大学科技研究公司 Glucagon/glp-1 receptor co-agonists
RU2014101697A (en) 2011-06-22 2015-07-27 Индиана Юниверсити Рисерч Энд Текнолоджи Корпорейшн Glucagon receptor coagonists / GLP-1
RU2014117678A (en) 2011-11-17 2015-12-27 Индиана Юниверсити Рисерч Энд Текнолоджи Корпорейшн Glucagon superfamily peptides with glucocorticoid receptor activity
EP2864351B1 (en) 2012-06-21 2016-08-10 Indiana University Research and Technology Corporation Glucagon analogs exhibiting gip receptor activity
US20160024169A1 (en) 2013-03-14 2016-01-28 Indiana University Research And Technology Corporation Insulin-incretin conjugates
WO2016049190A1 (en) 2014-09-24 2016-03-31 Indiana University Research And Technology Corporation Incretin-insulin conjugates
US9815886B2 (en) 2014-10-28 2017-11-14 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
US10259865B2 (en) 2017-03-15 2019-04-16 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6150584A (en) * 1990-01-12 2000-11-21 Abgenix, Inc. Human antibodies derived from immunized xenomice
US6075181A (en) * 1990-01-12 2000-06-13 Abgenix, Inc. Human antibodies derived from immunized xenomice
US6592876B1 (en) * 1993-04-20 2003-07-15 Uab Research Foundation Pneumococcal genes, portions thereof, expression products therefrom, and uses of such genes, portions and products
US5955089A (en) * 1993-04-20 1999-09-21 Uab Research Foundation Strain selection of pneumococcal surface proteins
WO1995031480A1 (en) * 1994-05-18 1995-11-23 S.P.I. Synthetic Peptides Incorporated Heterodimer polypeptide immunogen carrier composition and method
US5824483A (en) * 1994-05-18 1998-10-20 Pence Inc. Conformationally-restricted combinatiorial library composition and method
AU4645396A (en) * 1994-12-30 1996-07-24 University Of North Carolina At Chapel Hill, The Synthetic multimeric peptide with delta hepatitis virus antigenic activity
PT1140157E (en) * 1998-12-21 2009-05-06 Medimmune Inc Streptococcus pneumoniae proteins and immunogenic fragments for vaccines
AU5666300A (en) * 1999-06-25 2001-01-31 Robert S. Hodges Polypeptide compositions formed using a coiled-coil template and methods of use

Also Published As

Publication number Publication date
US20030021795A1 (en) 2003-01-30
CA2410604A1 (en) 2001-12-20
EP1290019A2 (en) 2003-03-12
WO2001096368A2 (en) 2001-12-20
WO2001096368A3 (en) 2002-05-02
JP2004503565A (en) 2004-02-05

Similar Documents

Publication Publication Date Title
AU2001269833A1 (en) Use of coiled-coil structural scaffold to generate structure-specific peptides
IL154305A0 (en) INHIBITION OF alpha4 MEDIATED CELL ADHESION
AU2001293564A1 (en) Point of sale terminal
AU2001288477A1 (en) Production of cyclic terpenoids
AU2002220832A1 (en) Improvements to disconnect devices
AU2001285272A1 (en) Scaffolding for bridges and other structures
AU2469099A (en) Cleansing compositions
AU2001262691A1 (en) Cosmetic preparation
AU4086301A (en) Improvements relating to converters
AU2001265341A1 (en) Process to prepare sulfonamides
AU2002210703A1 (en) Improvements to polymerisation processes
AU2001280436A1 (en) Process to increase protein stability
AU7065500A (en) Compounds useful to mimic peptide beta-strands
GB0023439D0 (en) Detection of fluoride
AU2001247585A1 (en) Fail to pots architecture
AU2001240841A1 (en) Analogue-to-digital conversion arrangement
AU2001250217A1 (en) Remote point of sale system
AU2002212134A1 (en) Use of trixepans in the process to modify (co) polymers
AU2001249886A1 (en) High q structure
AU2001277750A1 (en) Use of polypeptide
AU2001286584A1 (en) Inhibition of protein-protein interaction
AU2001286032A1 (en) Storage and conversion of compositions
AU5089000A (en) Improvements relating to builders' scaffolding
AU2002226353A1 (en) Cosmetic microemulsions
AU2765001A (en) Purification of microglial cells